Literature DB >> 24528040

Breast cancer in Iraq, incidence trends from 2000-2009.

Muzahem Mohammed Yahya Al-Hashimi1, Xiang Jun Wang.   

Abstract

BACKGROUND: Breast cancer is the most frequent malignancy of women worldwide. In Iraq, breast cancer ranks first among cancers diagnosed in women but no studies have been conducted on incidence trends. The present study of breast cancer in the country during 2000-2009 was therefore performed.
MATERIALS AND METHODS: The registered data for breast cancer cases were collected from the Iraqi Cancer Registry/Ministry of Health. The significance of incidence rate trends during 2000-2009 was tested using Poisson regression. Age-standardized rates (ASR), and age-specific rates per 100,000 population were calculated.
RESULTS: A total of 23,792 incident breast cancer cases were registered among females aged ≥15 years, represented 33.8% of all cancers in females registered during 2000-2009. It ranked first in all the years. The median age at diagnosis was 49 and the mean age was 52 years. The incidence rate of all female breast cancer in Iraq (all ages) increased from 26.6 per 100,000 in 2000 to 31.5 per 100,000 in 2009 (APC=1.14%, p<.0001). The incidence in age groups (40-49), (50-59) and (70+) increased in earlier years and has recently (2005-2009) become stable. The incidence in age group (60-69) did not decline since 2003, while the incidence rates in the age group (15-39) started to decline in 2004.
CONCLUSIONS: With the Iraqi Cancer Registry data during the period 2000-2009, the incidence of all female breast cancer in Iraq (all ages) has risen. We found rapid increase in the age specific incidence rate among age group 60-69. However, breast cancer among Iraqi women still affects younger age groups than their counterparts in developed countries. Further epidemiological research is needed to examine possible causes and prevention measures.

Entities:  

Mesh:

Year:  2014        PMID: 24528040     DOI: 10.7314/apjcp.2014.15.1.281

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Trends in Breast Cancer Incidence in Iraq During the Period 2000-2019.

Authors:  Muzahem M Y Al-Hashimi
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

2.  Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age.

Authors:  Runnak A Majid; Hemin A Hassan; Dana N Muhealdeen; Hazha A Mohammed; Michael D Hughson
Journal:  BMC Womens Health       Date:  2017-04-07       Impact factor: 2.809

3.  The cardiotoxicity effect of different chemotherapeutic regimens in Iraqi patients with breast cancer: A follow up study.

Authors:  Zainab Nazar Hasan Anber; Basil Oied Mohammed Saleh; Safana Ali Al-Rawi
Journal:  Heliyon       Date:  2019-08-01

4.  Predicting Characteristics Associated with Breast Cancer Survival Using Multiple Machine Learning Approaches.

Authors:  Mohammad Nazmul Haque; Tahia Tazin; Mohammad Monirujjaman Khan; Shahla Faisal; Sobhee Md Ibraheem; Haneen Algethami; Faris A Almalki
Journal:  Comput Math Methods Med       Date:  2022-04-25       Impact factor: 2.809

5.  Machine Learning Based Comparative Analysis for Breast Cancer Prediction.

Authors:  Mohammad Monirujjaman Khan; Somayea Islam; Srobani Sarkar; Foyazel Iben Ayaz; Morsaleen Kabeer Ananda; Tahia Tazin; Amani Abdulrahman Albraikan; Faris A Almalki
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

6.  Secular trend analysis of lung cancer incidence in Sihui city, China between 1987 and 2011.

Authors:  Jin-Lin Du; Xiao Lin; Li-Fang Zhang; Yan-Hua Li; Shang-Hang Xie; Meng-Jie Yang; Jie Guo; Er-Hong Lin; Qing Liu; Ming-Huang Hong; Qi-Hong Huang; Zheng-Er Liao; Su-Mei Cao
Journal:  Chin J Cancer       Date:  2015-07-31

7.  The prediction incidence of the three most common cancers among Iranian military community during 2007-2019: a time series analysis.

Authors:  A R Khoshdel; Y Alimohamadi; M Ziaei; H R Ghaffari; S Azadi; M Sepandi
Journal:  J Prev Med Hyg       Date:  2019-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.